Electromed (NYSE:ELMD) Cut to “Buy” at StockNews.com

StockNews.com downgraded shares of Electromed (NYSE:ELMD) from a strong-buy rating to a buy rating in a report published on Wednesday morning.

Electromed Price Performance

Electromed stock opened at $27.97 on Wednesday. The stock’s 50 day moving average is $31.40 and its 200 day moving average is $25.26. Electromed has a one year low of $13.74 and a one year high of $35.56. The firm has a market cap of $239.42 million, a P/E ratio of 37.29 and a beta of 0.33.

Insider Activity

In other news, Director Kathleen Skarvan sold 38,954 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $29.28, for a total value of $1,140,573.12. Following the transaction, the director now directly owns 32,622 shares of the company’s stock, valued at $955,172.16. The trade was a 54.42 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Andrew Summers sold 12,731 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total value of $381,675.38. Following the sale, the director now directly owns 165,755 shares of the company’s stock, valued at $4,969,334.90. This represents a 7.13 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 77,788 shares of company stock valued at $2,326,350. 14.00% of the stock is currently owned by insiders.

Institutional Trading of Electromed

Several hedge funds have recently modified their holdings of the stock. Squarepoint Ops LLC grew its holdings in Electromed by 7.8% in the fourth quarter. Squarepoint Ops LLC now owns 11,366 shares of the company’s stock worth $336,000 after purchasing an additional 823 shares during the period. Two Sigma Advisers LP acquired a new stake in shares of Electromed in the 4th quarter valued at about $219,000. Two Sigma Investments LP acquired a new stake in shares of Electromed in the 4th quarter valued at about $1,255,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Electromed in the 4th quarter valued at about $119,000. Finally, OMERS ADMINISTRATION Corp acquired a new position in Electromed during the 4th quarter worth approximately $736,000. Institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.